| 05/2023 – Now |
Scoring familial risks using pedigree-based BLUP
|
Finnish Institute for Molecular Medicine | BLUP; Prediction |
| 02/2023 – Now |
Cardiovascular risk prediction in diabetes |
University of Edinburgh |
NLP; Prediction |
| 05/2020 – 02/2022 |
A smart tool for querying registry data
|
Finnish Institute for Molecular Medicine | NLP; Classification |
| 08/2020 – 12/2020 |
Risk query and calculation
|
Finnish Institute for Molecular Medicine | NLP; Prediction |
| 10/2019 – 05/2020 |
Ph+ CML / ALL Market Sizing Analysis
|
Takeda Pharmaceuticals | Prediction |
| 08/2017 – 08/2018 |
Clinical Pathway Extraction and Clustering
|
Dana Farber Cancer Institute | NLP; Clustering |
| 01/2017 – 07/2017 |
Clinical Analytics Platform Development
|
Dana Farber Cancer Institute | NLP; Note Classification |